Poland· PL-100364012

Ezoleta

A ezetimibe product containing ezetimibum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 17 of our 19 countries.

ATC C10AX09

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ezetimibumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ezetimibe is registered in 17 of 19 countries.

Countries holding a registration under ATC C10AX09 (ezetimibe), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search ezetimibe products by name

Ezetimibe · ATC C10AX09

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ezetimibe costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.067 in United States to $1.32 in Switzerland — a ×20 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Ezetimibe · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.32
IT Italy$0.80
FR France$0.45
US United States$0.067 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Ezetimibum
Manufacturer: Krka, d.d., Novo mesto
Country: Poland (PL)
ATC code: C10AX09
ATC class: Ezetimibe
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 18

1 priced

gtin
05909991311407
30 szt.
PLN 14.3
gtin
05909991311421
gtin
05909991311438
gtin
05909991311445
gtin
05909991311452
gtin
05909991311469
gtin
05909991311476
gtin
05909991311483
gtin
05909991311490
gtin
05909991311506
gtin
05909991314682
gtin
05909991314699
gtin
05909991311353
gtin
05909991311360
gtin
05909991311377
gtin
05909991311384
gtin
05909991311391
gtin
05909991311414

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

236 interactions on record for ezetimibe.

Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ezetimibe against other medicines How interaction checks work

Ezetimibe · interactions on record

236 records

23 moderate
2 minor
210 info

Most severe, free to view

Chenodeoxycholic acidA05AA01moderate
EluxadolineA07DA06moderate
EltrombopagB02BX05moderate
SimvastatinC10AA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ezetimibe in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Ezegelan, Ezetimib +pharma
Belgium · Ezetimib Ab, Ezetimibe Eg
Bulgaria · Езен, Езетимиб Адамед
Cyprus · Erezel, Ezetimibe Accord
Czechia · Egitim, Ezen
Germany · Ezetad, Ezetimib 1 A Pharma
Denmark · Carditimib, Cildar
Estonia · Ezetimibe Accord, Ezetimibe Elvim
Spain · Absorcol, Azibe
Finland · Ezetimib Krka, Ezetimib Liconsa
France · Ezetimibe Accord, Ezetimibe Almus
United Kingdom (Northern Ireland) · Ezetimibe, Ezetimibe 10mg
Greece · Cildar, Delipid
Croatia · Elanix, Ezetrol
Hungary · Coltowan, Ezetimib Egis
Ireland · Ezetimibe Accord Healthcare Ireland, Ezetimibe Krka
Iceland · Ezetimib Actavis, Ezetimib Krka
Italy · Absorcol, Corintus
Lithuania · Coltowan, Ezetimibe Elvim
Luxembourg · Ezetimib Ratiopharm, Ezetimibe Eg
Latvia · Ezetimibe Accord, Ezetimibe Elvim
Malta · Ezetimibe Msn, Ezoleta
Netherlands · Ezdivule, Ezetimibe Accord
Norway · Ezetimib Actavis, Ezetimib Krka
Portugal · Ezetimiba Alter, Ezetimiba Aristo
Romania · Cexado, Coltowan
Sweden · Ezetimib Actavis, Ezetimib Krka
Slovenia · Elanix, Ezetrol
Slovakia · Ezen, Ezetimib Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/da517db1-bf42-4c9e-a48f-93b815c5f487
GET /v1/drugs/da517db1-bf42-4c9e-a48f-93b815c5f487?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909991311353 ¦ Rp ¦ 119978\n14 tabl. w blistrze perforowanym\n05909991311360 ¦ Rp ¦ 119979\n14 tabl. w blistrze\n05909991311377 ¦ Rp ¦ 119980\n28 tabl. w blistrze\n05909991311384 ¦ Rp ¦ 119981\n28 tabl. w blistrze perforowanym\n05909991311391 ¦ Rp ¦ 119982\n30 tabl. w blistrze perforowanym\n05909991311407 ¦ Rp ¦ 119983\n30 tabl. w blistrze\n05909991311414 ¦ Rp ¦ 119984\n50 tabl. w blistrze perforowanym\n05909991311421 ¦ Rp ¦ 119985\n50 tabl. w blistrze\n05909991311438 ¦ Rp ¦ 119986\n60 tabl. w blistrze\n05909991311445 ¦ Rp ¦ 119987\n60 tabl. w blistrze perforowanym\n05909991311452 ¦ Rp ¦ 119988\n90 tabl. w blistrze perforowanym\n05909991311469 ¦ Rp ¦ 119989\n90 tabl. w blistrze\n05909991311476 ¦ Rp ¦ 119990\n98 tabl. w blistrze perforowanym\n05909991311483 ¦ Rp ¦ 119991\n98 tabl. w blistrze\n05909991311490 ¦ Rp ¦ 119992\n100 tabl. w blistrach perforowanych\n05909991311506 ¦ Rp ¦ 119993\n100 tabl. w blistrze\n05909991314682 ¦ Rp ¦ 120343\n56 tabl. w blistrze\n05909991314699 ¦ Rp ¦ 120344\n56 tabl. w blistrze perforowanym",
  "substance": "Ezetimibum 10 mg",
  "common_name": "Ezetimibum",
  "pl_product_id": "100364012",
  "pozwolenie_nr": "23714",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console